<p>India's health ministry rejected reports on Wednesday that the country's drugs regulator had declined emergency authorisation for the AstraZeneca Covid-19 vaccine candidate and one developed locally by Bharat Biotech.</p>.<p>Broadcasters <em>NDTV</em> and <em>CNBC-TV18</em> reported that India's Central Drugs Standard Control Organization (CDSCO) had sought more data from the drugmakers after deliberating on applications made in the past three days.</p>.<p>A source with direct knowledge of the matter told Reuters that a decision on the vaccines would be taken "in toto" and it was too early to say whether they would be rejected or accepted.</p>.<p><a href="https://www.deccanherald.com/science-and-environment/coronavirus-vaccine-live-updates-covaxin-clinical-trials-human-trials-coronavirus-vaccine%20tracker-india-russia-us-china-oxford-moderna-bharat-biotech-866148.html" target="_blank"><strong>Coronavirus vaccine news live updates on DH</strong></a></p>.<p>India's health ministry denied the reports in a statement on Twitter. The government had said on Tuesday that some vaccines may be approved in the coming weeks.</p>.<p>The Serum Institute of India, which is the local manufacturer of the AstraZeneca vaccine, only applied for emergency approval on Monday.</p>.<p>The SII did not immediately respond to a request for comment. Bharat Biotech declined to comment. The CDSCO did not immediately respond to a request for comment.</p>.<p><em>NDTV</em> said the CDSCO did not consider a similar application from Pfizer Inc because their US experts could not attend the Wednesday meeting. </p>
<p>India's health ministry rejected reports on Wednesday that the country's drugs regulator had declined emergency authorisation for the AstraZeneca Covid-19 vaccine candidate and one developed locally by Bharat Biotech.</p>.<p>Broadcasters <em>NDTV</em> and <em>CNBC-TV18</em> reported that India's Central Drugs Standard Control Organization (CDSCO) had sought more data from the drugmakers after deliberating on applications made in the past three days.</p>.<p>A source with direct knowledge of the matter told Reuters that a decision on the vaccines would be taken "in toto" and it was too early to say whether they would be rejected or accepted.</p>.<p><a href="https://www.deccanherald.com/science-and-environment/coronavirus-vaccine-live-updates-covaxin-clinical-trials-human-trials-coronavirus-vaccine%20tracker-india-russia-us-china-oxford-moderna-bharat-biotech-866148.html" target="_blank"><strong>Coronavirus vaccine news live updates on DH</strong></a></p>.<p>India's health ministry denied the reports in a statement on Twitter. The government had said on Tuesday that some vaccines may be approved in the coming weeks.</p>.<p>The Serum Institute of India, which is the local manufacturer of the AstraZeneca vaccine, only applied for emergency approval on Monday.</p>.<p>The SII did not immediately respond to a request for comment. Bharat Biotech declined to comment. The CDSCO did not immediately respond to a request for comment.</p>.<p><em>NDTV</em> said the CDSCO did not consider a similar application from Pfizer Inc because their US experts could not attend the Wednesday meeting. </p>